RNAnalytics
Private Company
Total funding raised: $1.7M
Overview
RNAnalytics is building an operating system for RNA nanoparticle analytics, addressing critical bottlenecks in characterization and regulatory filing for lipid nanoparticle (LNP)-based therapeutics. Its wedge product, RNABOX, is a consumable toolkit for standardized wet-lab execution on existing instruments, starting with nanoparticle sizing and followed by an encapsulation efficiency module. The complementary RNAOS software platform automates workflows, ensures auditability, and structures data for regulatory submission, aiming to capture margin and defensibility as adoption grows. The company is in early commercial traction with paid pilots and plans a full platform launch.
Technology Platform
Integrated platform combining validated physical toolkits (RNABOX) for standardized wet-lab nanoparticle analytics with a cloud-native software hub (RNAOS) for workflow automation, audit trails, and CTD-aligned regulatory reporting.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
RNAnalytics competes with established particle characterization instrument companies (e.g., Malvern Panalytical, Horiba) that offer proprietary software, and with CROs providing analytical services. Its differentiation lies in the integrated hardware/software approach, a specific focus on RNA/LNP resolution, and a CTD-native data model designed for regulatory submission efficiency, rather than being a general-purpose analysis tool.